Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000169194 | SCV000220441 | likely pathogenic | Achromatopsia 3 | 2014-06-22 | criteria provided, single submitter | literature only | |
Labcorp Genetics |
RCV001380985 | SCV001579228 | pathogenic | not provided | 2024-03-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg216*) in the CNGB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CNGB3 are known to be pathogenic (PMID: 28795510). This variant is present in population databases (rs768345097, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with achromatopsia (PMID: 15657609, 28795510). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 188844). For these reasons, this variant has been classified as Pathogenic. |
Molecular Genetics Laboratory, |
RCV000169194 | SCV000575825 | pathogenic | Achromatopsia 3 | 2017-03-27 | no assertion criteria provided | research | |
Natera, |
RCV001831988 | SCV002076098 | pathogenic | Achromatopsia | 2020-03-18 | no assertion criteria provided | clinical testing |